Rapid method for generating safe live attenuated vaccines for viral disease prevention

Summary:

A Singapore-based institute has developed a rapid and reliable method for generating safe live attenuated vaccines (LAVs). Traditionally, attenuated strains are developed through serial passage in cell lines or in animals. This chance discovery can take years with no guarantee of success. With this new technology, it takes just 10 weeks for generation of a suitable LAV candidate.

The institute seeks to partner SMEs, MNEs and healthcare organisations via license or research agreements.

Reference: TOSG20190114002

Country: Singapore

Submitted: 20. 12. 2019

View Partnering Opportunity

Keywords

Technology: Human vaccines

Market: Drug delivery and other equipment

NACE: Manufacture of basic pharmaceutical products, Manufacture of pharmaceutical preparations

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.